ATE169502T1 - Verfahren zur erhaltung einer ueberstandsfraktion von aktivierten thrombozyten - Google Patents

Verfahren zur erhaltung einer ueberstandsfraktion von aktivierten thrombozyten

Info

Publication number
ATE169502T1
ATE169502T1 AT93913100T AT93913100T ATE169502T1 AT E169502 T1 ATE169502 T1 AT E169502T1 AT 93913100 T AT93913100 T AT 93913100T AT 93913100 T AT93913100 T AT 93913100T AT E169502 T1 ATE169502 T1 AT E169502T1
Authority
AT
Austria
Prior art keywords
thrombocytes
pct
supermanent
fraction
obtaining
Prior art date
Application number
AT93913100T
Other languages
English (en)
Inventor
Olivier Marcel Joseph Delmas
Original Assignee
Inoteb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inoteb filed Critical Inoteb
Application granted granted Critical
Publication of ATE169502T1 publication Critical patent/ATE169502T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/02—Blood transfusion apparatus
    • A61M1/0209—Multiple bag systems for separating or storing blood components
    • A61M1/0218—Multiple bag systems for separating or storing blood components with filters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A61M2202/0427—Platelets; Thrombocytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AT93913100T 1992-06-05 1993-06-07 Verfahren zur erhaltung einer ueberstandsfraktion von aktivierten thrombozyten ATE169502T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9206826A FR2691911B1 (fr) 1992-06-05 1992-06-05 Dispositif permettant l'obtention d'un surnageant de thrombocytes activés, procédé mettant en Óoeuvre le dispositif et surnageant obtenu.

Publications (1)

Publication Number Publication Date
ATE169502T1 true ATE169502T1 (de) 1998-08-15

Family

ID=9430469

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93913100T ATE169502T1 (de) 1992-06-05 1993-06-07 Verfahren zur erhaltung einer ueberstandsfraktion von aktivierten thrombozyten

Country Status (10)

Country Link
US (1) US5618663A (de)
EP (1) EP0643582B1 (de)
JP (1) JPH07507558A (de)
AT (1) ATE169502T1 (de)
CA (1) CA2137271C (de)
DE (1) DE69320342T2 (de)
DK (1) DK0643582T3 (de)
ES (1) ES2123055T3 (de)
FR (1) FR2691911B1 (de)
WO (1) WO1993025215A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19733899A1 (de) * 1997-08-05 1999-02-11 Ingo Flesch Verfahren und Vorrichtung zur Herstellung autologer, thrombozytärer Wachstumsfaktoren sowie System als Bestandteil einer Vorrichtung zur Herstellung autologer, thrombozytärer Wachtstumsfaktoren
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
JP4564143B2 (ja) * 2000-07-27 2010-10-20 テルモ株式会社 血小板活性化剤を含まない血小板放出因子及びこの調製方法
EP1464697B1 (de) * 2002-01-09 2011-06-08 Alberto Gorrochategui Barrueta Zusammensetzung zur herstellung, regeneration und reparatur von geweben unter verwendung eines zellentragenden biologischen implantats, das mit einem blutplättchenkonzentrat und supplementen angereichert ist
US20070141036A1 (en) * 2002-01-09 2007-06-21 Alberto Gorrochategui Barrueta Composition and procedure for tissue creation, regeneration and repair by a cell-bearing biological implant enriched with platelet concentrate and supplements
ES2221770B2 (es) * 2002-04-19 2006-07-16 Eduardo Anitua Aldecoa Metodo de preparacion de un compuesto para la regeneracion de tejidos.
US7374678B2 (en) * 2002-05-24 2008-05-20 Biomet Biologics, Inc. Apparatus and method for separating and concentrating fluids containing multiple components
US7992725B2 (en) 2002-05-03 2011-08-09 Biomet Biologics, Llc Buoy suspension fractionation system
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US7179391B2 (en) 2002-05-24 2007-02-20 Biomet Manufacturing Corp. Apparatus and method for separating and concentrating fluids containing multiple components
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
TW200505394A (en) * 2003-06-06 2005-02-16 Asahi Medical Co Material promoting wound healing
US20070122906A1 (en) * 2003-12-29 2007-05-31 Allan Mishra Method of culturing cells
DE102004018347A1 (de) * 2004-04-06 2005-10-27 Manfred Dr. Schmolz Wundheilungsfördende Botenstoffmischung
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8430813B2 (en) * 2006-05-26 2013-04-30 Depuy Spine, Inc. Illuminated surgical access system including a surgical access device and integrated light emitter
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
WO2008127639A1 (en) 2007-04-12 2008-10-23 Biomet Biologics, Llc Buoy suspension fractionation system
US8835104B2 (en) 2007-12-20 2014-09-16 Fenwal, Inc. Medium and methods for the storage of platelets
EP2077118A1 (de) 2008-01-07 2009-07-08 Gwo Rei Biomedical Technology Corp. Gerinnungsfähiges Konzentrat von Plättchenwachstumsfaktoren und Herstellungsverfahren dafür
PL2259774T3 (pl) 2008-02-27 2013-04-30 Biomet Biologics Llc Sposoby i kompozycje dla wprowadzania antagonisty receptora interleukiny-1
US8337711B2 (en) 2008-02-29 2012-12-25 Biomet Biologics, Llc System and process for separating a material
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
EP3662750A1 (de) 2011-04-07 2020-06-10 Fenwal, Inc. Automatisierte verfahren und systeme zur bereitstellung von thrombozytenkonzentraten mit reduziertem restplasmavolumen und medien zur lagerung solcher thrombozytenkonzentrate
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US20140356893A1 (en) 2013-06-04 2014-12-04 Allan Mishra Compositions and methods for using platelet-rich plasma for drug discovery, cell nuclear reprogramming, proliferation or differentiation
FR3099703B1 (fr) * 2019-08-09 2023-05-19 Maco Pharma Sa Système à poches pour la collecte du sang chez l’animal

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4360435A (en) * 1979-11-01 1982-11-23 Baxter Travenol Laboratories, Inc. Process for sterilizing and transferring a solution
US4360425A (en) * 1981-09-14 1982-11-23 American Cyanamid Company Low molecular weight copolymers and terpolymers as depressants in mineral ore flotation
NL8202703A (nl) * 1981-10-01 1983-05-02 Cobe Lab Werkwijze en inrichting voor het afscheiden van vloeistoffiltraten, die vrij zijn van deeltjes groter dan een voorafbepaalde afmeting, uit vloeistofmengsels van de deeltjes.
US4479896A (en) * 1981-12-11 1984-10-30 Antoniades Harry N Method for extraction localization and direct recovery of platelet derived growth factor
US4410630A (en) * 1981-12-11 1983-10-18 The United States Of America As Represented By The Department Of Health And Human Services Lysis filtration culture chamber
EP0116626B1 (de) * 1982-08-24 1988-10-12 BAXTER INTERNATIONAL INC. (a Delaware corporation) Blutsammelsystem und verfahren
US4618494A (en) * 1984-07-20 1986-10-21 Immunology Development Corporation Human Immune Factors and processes for their production and use
JPH0611320B2 (ja) * 1984-10-02 1994-02-16 旭メデイカル株式会社 血液透析用中空糸膜
WO1986003122A1 (en) * 1984-11-29 1986-06-05 Curatech, Inc. Wound healing agents
US4957742A (en) * 1984-11-29 1990-09-18 Regents Of The University Of Minnesota Method for promoting hair growth
US4731260A (en) * 1984-12-18 1988-03-15 American Hospital Supply Corporation Hydrophobic filter material and method
FR2582960B1 (fr) * 1985-06-11 1989-09-15 Adria Procede et appareil destines a la filtration sur membrane d'un produit tel que le lait, en vue de l'analyse des produits de filtration
US4760131A (en) * 1986-04-23 1988-07-26 Collagen Corporation Wound-healing composition
EP0289584B1 (de) * 1986-11-14 1993-05-05 Institute of Molecular Biology, Inc. Wundheilung und knochenregeneration
JPH01121061A (ja) * 1987-11-05 1989-05-12 Nissho Corp 血小板分離フィルター
US4874746A (en) * 1987-12-22 1989-10-17 Institute Of Molecular Biology, Inc. Wound headling composition of TGF-alpha and PDGF
EP0323842A3 (de) * 1988-01-07 1990-04-25 Otsuka Pharmaceutical Co., Ltd. Methode für die Säuberung von umbildendem Wachstums-Faktor-Beta
AU617265B2 (en) * 1988-06-23 1991-11-21 Asahi Medical Co. Ltd. Method for separating blood into blood components, and blood components separator unit

Also Published As

Publication number Publication date
FR2691911B1 (fr) 1994-11-25
DK0643582T3 (da) 1999-05-17
DE69320342D1 (de) 1998-09-17
CA2137271C (fr) 2005-03-29
EP0643582A1 (de) 1995-03-22
EP0643582B1 (de) 1998-08-12
CA2137271A1 (fr) 1993-12-23
US5618663A (en) 1997-04-08
WO1993025215A1 (fr) 1993-12-23
DE69320342T2 (de) 1999-04-08
FR2691911A1 (fr) 1993-12-10
JPH07507558A (ja) 1995-08-24
ES2123055T3 (es) 1999-01-01

Similar Documents

Publication Publication Date Title
ATE169502T1 (de) Verfahren zur erhaltung einer ueberstandsfraktion von aktivierten thrombozyten
DE3785993D1 (de) Filtermedium zur selektiven beseitigung von leucocyten.
DE69132172D1 (de) Verfahren zur Abtrennung von Blutkomponenten aus Vollblut
ATE113468T1 (de) Verfahren zur trennung von teilchen nach grösse.
SE8601891D0 (sv) Maskin for plasmabytesbehandling och trombocytgivning
DE68928956D1 (de) Verfahren zur Herstellung von optisch aktivem 1,3-Butanediol
DE68919053D1 (de) Verfahren zur Herstellung von Aluminoxanen.
DE68920359D1 (de) Verfahren zur Herstellung von Farbkonzentrat.
ATE171640T1 (de) Vorrichtung zur filtration von teilchenenthaltenden flüssigkeiten
DE68914001D1 (de) Verfahren zur Herstellung von Elektretfiltern.
DE3687453D1 (de) Einrichtung zur filtration von plasma aus blut.
DE68914146D1 (de) Verfahren zur herstellung von einzelkristallen.
DE68905403D1 (de) Verfahren zur erniedrigung des truebungspunktes von materialien unter anwendung eines ultrafiltrations-separationsprozesses.
DE3789477D1 (de) Vorrichtung für Anwendung in der Kanalisation von Blutgefässen.
DE3789635D1 (de) Verfahren zur Verleimung von wasserdurchdringbaren Zelluloseteilchen.
DE3772342D1 (de) Verfahren zur abtrennung von phosphinischen verunreinigungen aus hoeheren olefinen.
DE69019614D1 (de) Filter zur automatischen Reinigung von Flüssigkeitskreisläufen.
DE3762746D1 (de) Galliumhydrid/trialkylamin addukte und ihre anwendung zur ablagerung von filmen von iii-v-verbindungen.
DE68919793D1 (de) Verfahren zur Herstellung von Kristallen aus wasserfreiem Natriumsulfid.
ATE92075T1 (de) Verfahren zur gewinnung aktiver proteine aus einer biologisch inaktiven form.
DE59004588D1 (de) Verfahren zur Herstellung von Purpurmembran enthaltend Bacteriorhodopsin.
DE58906606D1 (de) Optisch aktive Rhodiumkomplexe von 3,4-Bis(diarylphosphino)-pyrrolidinen und ihre Verwendung zur Herstellung von Phosphinothricin durch asymmetrische Hydrierung.
DE68921787D1 (de) Verfahren zur Herstellung von N-Phosphonomethylglycin.
DE59007763D1 (de) Verfahren zur asymmetrischen Hydrierung von alpha-Ketocarbonyl-verbindungen zu optisch aktiven alpha-Hydroxycarbonylverbindungen.
DE68911603D1 (de) Verfahren zur Herstellung von 2-Pyrrolidon.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee